Convalescent Plasma for the Treatment of Severe COVID-19
Massimo Franchini, Giancarlo Maria Liumbruno Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, ItalyCorrespondence: Massimo FranchiniDepartment of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, ItalyTel +039-0376-201234Fax +039-0376-220144Email mass...
Guardado en:
Autores principales: | Franchini M, Liumbruno GM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f144f633a8249edb3bfb220096af548 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
por: Cathrine Axfors, et al.
Publicado: (2021) -
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
por: Karin Holm, et al.
Publicado: (2021) -
SEIR Mathematical Model of Convalescent Plasma Transfusion to Reduce COVID-19 Disease Transmission
por: Hennie Husniah, et al.
Publicado: (2021) -
Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia
por: Maamoun Basheer, et al.
Publicado: (2021) -
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
por: Theresia Monica Rahardjo, et al.
Publicado: (2021)